ClinicalTrials.Veeva

Menu

Artificial Shrinkage for Human Blastocyst Prior Vitrification (AS)

D

Dar AlMaraa Center

Status

Unknown

Conditions

Vitrification

Treatments

Procedure: Artificial shrinkage

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Investigators aim to investigate the effect of elimination of blastocoelic fluid by creating a large hole in the zona pellucida at the cellular junction of the trophectoderm cells located far away from the inner cell mass with a laser pulse before vitrification.

Full description

Human blastocyst formation begins about 5 days after injecting a single sperm into an oocyte in ICSI cycle or incubation of them in IVF cycle. Human blastocyst consists of cells forming an outer layer called trophotoderm that will form the placenta in case of successful implantation, an inner cell mass which become the fetus, a fluid-filled blastocoel cavity in the center, and a surrounding zone pellucida from which the embryo hatches to implant in the uterus. Human blastocyst contains a large amount of liquid in the blastocoel, which alters the infiltration of vitrification solution during the vitrification procedures leading to ice crystal formation. Therefore, investigators need to compare blastocyst survival, clinical pregnancy and implantation rates between vitrified untreated expanded blastocysts and vitrified blastocysts with artificially eliminated blastocoels by a laser pulse prior to vitrification

Enrollment

100 estimated patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • BMI of ≤ 32

Exclusion criteria

  • Non-expanded blastocysts.
  • Women who had uterine pathology or abnormality.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

100 participants in 2 patient groups

Artificial shrinkage
Experimental group
Description:
Elimination of blastocoelic fluid by creating a large hole in the zona pellucida at the cellular junction of the trophectoderm cells located far away from the inner cell mass with a laser pulse before vitrification.
Treatment:
Procedure: Artificial shrinkage
Without Artificial shrinkage
No Intervention group
Description:
Vitrify expanded blastocysts.

Trial contacts and locations

1

Loading...

Central trial contact

Yasmin Magdi, M.Sc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems